Sacituzumab Tirumotecan in Pts w/ NEPC After Progression on Prior Chemotherapy
NCT07639086
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Neuroendocrine Prostate Cancer (NEPC)
Interventions
DRUG:
Sacituzumab Tirumotecan
Sponsor
Virginia Commonwealth University
Collaborators
[object Object]